Literature DB >> 21968608

Evaluation of the ability of collagen-glycosaminoglycan scaffolds with or without mesenchymal stem cells to heal bone defects in Wistar rats.

M Alhag1, E Farrell, M Toner, T Clive Lee, F J O'Brien, N Claffey.   

Abstract

PURPOSE: The aim of this experiment was to examine the capacity of collagen-glycosaminoglycan scaffolds, with or without mesenchymal stem cells, to satisfactorily repair a 5-mm rat calvarial defect.
METHODS: Fifty-five Wistar rats were used in the study. The defects were either left empty to serve as controls (n = 7) or filled with cell-free scaffolds (n = 11), cell-seeded scaffolds that were pre-cultured in standard culture medium (n = 13), cell-seeded scaffolds that were pre-cultured in osteoinductive factor-supplemented medium (n = 12) or particulate autogenous bone (n = 12). The animals were sacrificed at 12 weeks after surgery, and specimens were prepared for histomorphometric analysis. The linear bone healing and the bone area within the defect were measured.
RESULTS: Comparable results were obtained using cell-free collagen-glycosaminoglycan scaffolds and autogenous bone both in terms of linear bone healing (P < 0.986) and area of new bone (P < 0.846). While the test groups showed significantly more bone formation compared to the empty defect control group, the linear bone healing and area of new bone within the defect were significantly lower in the cell-seeded scaffolds than in the cell-free scaffolds. The results have demonstrated that a cell-free collagen-glycosaminoglycan scaffold is capable of repairing a 5-mm rat calvarial defect as effectively as autogenous bone and that seeding the scaffold with pre-cultured mesenchymal stem cells prior to implantation offered no beneficial effect and resulted in incomplete healing of the defect.
CONCLUSIONS: The results thus suggest that the scaffold has immense potential for tissue repair showing favorable osteoconductive properties, biocompatibility and degradability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968608     DOI: 10.1007/s10006-011-0299-0

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  44 in total

1.  The effect of pore size on cell adhesion in collagen-GAG scaffolds.

Authors:  F J O'Brien; B A Harley; I V Yannas; L J Gibson
Journal:  Biomaterials       Date:  2005-02       Impact factor: 12.479

Review 2.  Collagen scaffolds for tissue engineering.

Authors:  Julie Glowacki; Shuichi Mizuno
Journal:  Biopolymers       Date:  2008-05       Impact factor: 2.505

3.  Gene expression by marrow stromal cells in a porous collagen-glycosaminoglycan scaffold is affected by pore size and mechanical stimulation.

Authors:  Elaine M Byrne; Eric Farrell; Louise A McMahon; Matthew G Haugh; Fergal J O'Brien; Veronica A Campbell; Patrick J Prendergast; Brian C O'Connell
Journal:  J Mater Sci Mater Med       Date:  2008-06-27       Impact factor: 3.896

Review 4.  Stem cell technology and bioceramics: from cell to gene engineering.

Authors:  H Ohgushi; A I Caplan
Journal:  J Biomed Mater Res       Date:  1999

5.  Tendon cell contraction of collagen-GAG matrices in vitro: effect of cross-linking.

Authors:  D S Torres; T M Freyman; I V Yannas; M Spector
Journal:  Biomaterials       Date:  2000-08       Impact factor: 12.479

6.  A comparison of the osteogenic potential of adult rat mesenchymal stem cells cultured in 2-D and on 3-D collagen glycosaminoglycan scaffolds.

Authors:  E Farrell; E M Byrne; J Fischer; F J O'Brien; B C O'Connell; P J Prendergast; V A Campbell
Journal:  Technol Health Care       Date:  2007       Impact factor: 1.285

7.  Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model.

Authors:  Hirosato Inoda; Gaku Yamamoto; Takanori Hattori
Journal:  J Craniomaxillofac Surg       Date:  2004-12       Impact factor: 2.078

8.  Degradable and injectable poly(aldehyde guluronate) hydrogels for bone tissue engineering.

Authors:  K Y Lee; E Alsberg; D J Mooney
Journal:  J Biomed Mater Res       Date:  2001-08

9.  Different types of inflammatory reactions in peri-implant soft tissues.

Authors:  I Ericsson; L G Persson; T Berglundh; C P Marinello; J Lindhe; B Klinge
Journal:  J Clin Periodontol       Date:  1995-03       Impact factor: 8.728

10.  Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds.

Authors:  Fergal J O'Brien; Brendan A Harley; Ioannis V Yannas; Lorna Gibson
Journal:  Biomaterials       Date:  2004-03       Impact factor: 12.479

View more
  6 in total

1.  Non-viral gene-activated matrices: next generation constructs for bone repair.

Authors:  Erica G Tierney; Garry P Duffy; Sally-Ann Cryan; Caroline M Curtin; Fergal J O'Brien
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

Review 2.  Collagen scaffolds in bone sialoprotein-mediated bone regeneration.

Authors:  Thomas E Kruger; Andrew H Miller; Jinxi Wang
Journal:  ScientificWorldJournal       Date:  2013-03-31

3.  Enhanced osteogenesis and angiogenesis by mesoporous hydroxyapatite microspheres-derived simvastatin sustained release system for superior bone regeneration.

Authors:  Wei-Lin Yu; Tuan-Wei Sun; Chao Qi; Hua-Kun Zhao; Zhen-Yu Ding; Zhi-Wang Zhang; Ben-Ben Sun; Ji Shen; Feng Chen; Ying-Jie Zhu; Dao-Yun Chen; Yao-Hua He
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

Review 4.  Strategies for Bone Regeneration: From Graft to Tissue Engineering.

Authors:  Giulia Battafarano; Michela Rossi; Viviana De Martino; Francesco Marampon; Luca Borro; Aurelio Secinaro; Andrea Del Fattore
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

Review 5.  The development of collagen based composite scaffolds for bone regeneration.

Authors:  Dawei Zhang; Xiaowei Wu; Jingdi Chen; Kaili Lin
Journal:  Bioact Mater       Date:  2017-09-18

6.  The Impact of the Extracellular Matrix Environment on Sost Expression by the MLO-Y4 Osteocyte Cell Line.

Authors:  Robert T Brady; Fergal J O'Brien; David A Hoey
Journal:  Bioengineering (Basel)       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.